{"id":684,"date":"2024-11-28T11:17:39","date_gmt":"2024-11-28T11:17:39","guid":{"rendered":"https:\/\/genes2me.com\/blog\/?p=684"},"modified":"2024-11-28T11:17:39","modified_gmt":"2024-11-28T11:17:39","slug":"introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency","status":"publish","type":"post","link":"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/","title":{"rendered":"Introducing OnePCR by G2M: A Fully Automated Detection System with Seamless Sample-to-Result Efficiency"},"content":{"rendered":"\n
\"\"
OnePCR Testing Solution<\/strong><\/figcaption><\/figure>\n\n\n\n

G2M is excited to introduce OnePCR, a fully automated detection system<\/a> that transforms point-of-care testing. With its innovative design, OnePCR offers a simplified sample-to-result process that eliminates the need for transferring samples between devices. Utilizing advanced cartridge technology, it combines nucleic acid extraction and real-time PCR into a single integrated instrument, reducing the risk of human error and positioning OnePCR as the most efficient and dependable testing solution available.<\/p>\n\n\n\n

It is a simple “Sample In\u2014result out” device that streamlines the workflow, delivering fast and accurate diagnostics in under 90 minutes. With unmatched efficiency and reliability, OnePCR is poised to be a game-changer in point-of-care testing.<\/p>\n\n\n\n

Its Multi-Target Detection capability can identify up to 20 targets from a single sample, making it a highly versatile tool for comprehensive diagnostics. Equipped with a five-channel fluorescence system and an innovative circular cassette design, it ensures precise nucleic acid extraction and RT-PCR<\/a>-based fluorescence detection. OnePCR operates independently with robotic liquid handling, completing each run in 30-70 minutes, providing rapid and reliable results.<\/p>\n\n\n\n

\"\"
Fully Automated Nucleic Acid Detection System<\/figcaption><\/figure>\n\n\n\n

The system uses a single-use, disposable sealed extraction and PCR cartridge to prevent contact with the instrument, environment, or carryover contamination. Built-in HEPA filters and UV light sterilization ensure efficient, contamination-free results. Its compact, lightweight, and ergonomic design is complemented by built-in intuitive automated reporting software<\/a> for seamless operation.<\/p>\n\n\n\n

OnePCR is equipped with QR code scanning on the cartridge for quick access to experiment protocols and features user-friendly, intuitive built-in software to enhance efficiency and convenience. Designed to be used beyond traditional lab environments, it can be operated by semi-skilled personnel with ease. The system includes pre-filled cartridges for both extraction and amplification, eliminating the need for manual liquid transfers, and streamlining the process even further. OnePCR utilizes magnetic bead-based extraction technology, ensuring efficient and reliable nucleic acid extraction. Additionally, it can connect to multiple independent modules, allowing for multi-sample analysis, further enhancing its capacity and flexibility for high-throughput testing.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

About G2M<\/strong><\/h2>\n\n\n\n

As a leading manufacturer of in vitro diagnostic (IVD) solutions, G2M is at the forefront of advancing healthcare through innovation. G2M<\/a> has quickly established itself as a key player in the diagnostics industry, offering highly accurate, reliable, and competitively priced IVD solutions.<\/p>\n\n\n\n

The launch of OnePCR, a state-of-the-art fully automated detection system, represents a major milestone in G2M’s growth. By integrating nucleic acid extraction and RT-PCR detection into a single, streamlined process, OnePCR simplifies diagnostics. Its user-friendly design, rapid turnaround time, and high sensitivity make it an essential tool for faster, more accurate point-of-care testing.<\/p>\n\n\n\n

Beyond OnePCR, G2M\u2019s product portfolio includes advanced offerings such as RT-PCR IVD kits, nucleic acid extraction solutions<\/a>, and next-generation sequencing panels. With the introduction of OnePCR, G2M continues to push the boundaries of point-of-care testing, driving innovation and positioning itself as a trusted partner for healthcare providers.<\/p>\n","protected":false},"excerpt":{"rendered":"

G2M is excited to introduce OnePCR, a fully automated detection system that transforms point-of-care testing. With its innovative design, OnePCR offers a simplified sample-to-result process…<\/p>\n","protected":false},"author":1,"featured_media":692,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[5,236,304,235],"tags":[320,322,318,323,244,243,313,321,317,314,316,319,312,315],"yoast_head":"\nG2M Introduce OnePCR - Fully Automated Detection System, POC<\/title>\n<meta name=\"description\" content=\"G2M introduces OnePCR, a fully automated detection system revolutionizing POCT with streamlined sample-2-result processing. In just 30-70 mit\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"G2M Introduce OnePCR - Fully Automated Detection System, POC\" \/>\n<meta property=\"og:description\" content=\"G2M introduces OnePCR, a fully automated detection system revolutionizing POCT with streamlined sample-2-result processing. In just 30-70 mit\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/\" \/>\n<meta property=\"og:site_name\" content=\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-28T11:17:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2024\/11\/Primary-One-PCR-Banner-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"525\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Genes2Me\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Genes2Me\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/genes2me.com\/blog\/#organization\",\"name\":\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\",\"url\":\"https:\/\/genes2me.com\/blog\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg\",\"contentUrl\":\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg\",\"width\":150,\"height\":69,\"caption\":\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\"},\"image\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genes2me.com\/blog\/#website\",\"url\":\"https:\/\/genes2me.com\/blog\/\",\"name\":\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\",\"description\":\"Real Time PCR Molecular Diagnostics NGS Cancer Screening Sequencing COVID-19 Rapid Antigen Antibody Made in India Manufacturer Clinical\/Whole Exome\",\"publisher\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genes2me.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/\",\"url\":\"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/\",\"name\":\"G2M Introduce OnePCR - Fully Automated Detection System, POC\",\"isPartOf\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#website\"},\"datePublished\":\"2024-11-28T11:17:39+00:00\",\"dateModified\":\"2024-11-28T11:17:39+00:00\",\"description\":\"G2M introduces OnePCR, a fully automated detection system revolutionizing POCT with streamlined sample-2-result processing. In just 30-70 mit\",\"breadcrumb\":{\"@id\":\"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/genes2me.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Introducing OnePCR by G2M: A Fully Automated Detection System with Seamless Sample-to-Result Efficiency\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/\"},\"author\":{\"name\":\"Genes2Me\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa\"},\"headline\":\"Introducing OnePCR by G2M: A Fully Automated Detection System with Seamless Sample-to-Result Efficiency\",\"datePublished\":\"2024-11-28T11:17:39+00:00\",\"dateModified\":\"2024-11-28T11:17:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/\"},\"wordCount\":492,\"publisher\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#organization\"},\"keywords\":[\"analysis software\",\"automated nucleic acid detection system\",\"automated reporting software\",\"fully automated system\",\"g2m\",\"genes2me\",\"instruments\",\"nucleic acid detection system\",\"one pcr system\",\"rt pcr instruments\",\"rt pcr solutions\",\"software\",\"testing solution\",\"testing systems\"],\"articleSection\":[\"Diagnostics\",\"DNA RNA Solutions\",\"Point of Care Solution\",\"Real Time PCR Solutions\"],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa\",\"name\":\"Genes2Me\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g\",\"caption\":\"Genes2Me\"},\"description\":\"Established in 2016, Genes2Me is a leading molecular diagnostics company committed to transforming healthcare through innovative, high-quality in vitro diagnostic (IVD) solutions. Built on a strong foundation of scientific excellence and precision engineering, Genes2Me develops and manufactures advanced diagnostic technologies that enable accurate, reliable, and timely clinical decision-making across diverse healthcare settings worldwide. With a comprehensive and rapidly expanding portfolio, Genes2Me offers cutting-edge solutions across molecular diagnostics, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, RT-PCR kits and instruments, as well as nucleic acid extraction kits and automation systems. Designed to meet the evolving needs of modern laboratories and clinicians, our products combine performance, scalability, and operational efficiency. A vast majority of Genes2Me products are CE-IVD marked, reflecting our commitment to global quality benchmarks, regulatory compliance, and uncompromising product standards. At the heart of our innovation are proprietary platforms such as OnePCR and Rapi-Q, developed to deliver rapid, multiplex, and highly sensitive molecular detection with streamlined workflows and minimal turnaround time. OnePCR integrates automated nucleic acid extraction and RT-PCR into a single, seamless workflow, enabling the detection of up to 20 targets from a single sample with exceptional precision and efficiency. The Rapi-Q series is engineered for fast, sensitive, and multiplex testing with a larger throughput, empowering healthcare providers with timely diagnostic insights that support improved patient outcomes. In genomics, Genes2Me offers one of the industry\u2019s most comprehensive NGS clinical assay portfolios, spanning oncology, liquid biopsy, whole exome sequencing, NIPT and pharmacogenomics. Complementing this portfolio is EZY AutoPrep, our advanced automated library preparation workstation designed to optimize NGS library preparation through enhanced accuracy, reproducibility, and scalability. Our genomics ecosystem is further strengthened by CliSeq Interpreter, a cloud-based bioinformatics platform that enables accurate, flexible, and intuitive interpretation of complex genomic data, helping laboratories generate high-confidence insights with efficiency and ease. Driven by innovation, quality, and a global vision, Genes2Me continues to redefine the future of molecular diagnostics\u2014delivering integrated solutions that advance precision medicine and improve lives worldwide.\",\"sameAs\":[\"https:\/\/www.genes2me.com\/\"],\"url\":\"https:\/\/genes2me.com\/blog\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"G2M Introduce OnePCR - Fully Automated Detection System, POC","description":"G2M introduces OnePCR, a fully automated detection system revolutionizing POCT with streamlined sample-2-result processing. In just 30-70 mit","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/","og_locale":"en_US","og_type":"article","og_title":"G2M Introduce OnePCR - Fully Automated Detection System, POC","og_description":"G2M introduces OnePCR, a fully automated detection system revolutionizing POCT with streamlined sample-2-result processing. In just 30-70 mit","og_url":"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/","og_site_name":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","article_published_time":"2024-11-28T11:17:39+00:00","og_image":[{"width":700,"height":525,"url":"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2024\/11\/Primary-One-PCR-Banner-2.jpg","type":"image\/jpeg"}],"author":"Genes2Me","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Genes2Me","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/genes2me.com\/blog\/#organization","name":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","url":"https:\/\/genes2me.com\/blog\/","sameAs":[],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg","contentUrl":"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg","width":150,"height":69,"caption":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems"},"image":{"@id":"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/"}},{"@type":"WebSite","@id":"https:\/\/genes2me.com\/blog\/#website","url":"https:\/\/genes2me.com\/blog\/","name":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","description":"Real Time PCR Molecular Diagnostics NGS Cancer Screening Sequencing COVID-19 Rapid Antigen Antibody Made in India Manufacturer Clinical\/Whole Exome","publisher":{"@id":"https:\/\/genes2me.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genes2me.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/","url":"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/","name":"G2M Introduce OnePCR - Fully Automated Detection System, POC","isPartOf":{"@id":"https:\/\/genes2me.com\/blog\/#website"},"datePublished":"2024-11-28T11:17:39+00:00","dateModified":"2024-11-28T11:17:39+00:00","description":"G2M introduces OnePCR, a fully automated detection system revolutionizing POCT with streamlined sample-2-result processing. In just 30-70 mit","breadcrumb":{"@id":"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genes2me.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Introducing OnePCR by G2M: A Fully Automated Detection System with Seamless Sample-to-Result Efficiency"}]},{"@type":"Article","@id":"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/#article","isPartOf":{"@id":"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/"},"author":{"name":"Genes2Me","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa"},"headline":"Introducing OnePCR by G2M: A Fully Automated Detection System with Seamless Sample-to-Result Efficiency","datePublished":"2024-11-28T11:17:39+00:00","dateModified":"2024-11-28T11:17:39+00:00","mainEntityOfPage":{"@id":"https:\/\/genes2me.com\/blog\/2024\/11\/28\/introducing-onepcr-by-g2m-a-fully-automated-detection-system-with-seamless-sample-to-result-efficiency\/"},"wordCount":492,"publisher":{"@id":"https:\/\/genes2me.com\/blog\/#organization"},"keywords":["analysis software","automated nucleic acid detection system","automated reporting software","fully automated system","g2m","genes2me","instruments","nucleic acid detection system","one pcr system","rt pcr instruments","rt pcr solutions","software","testing solution","testing systems"],"articleSection":["Diagnostics","DNA RNA Solutions","Point of Care Solution","Real Time PCR Solutions"],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa","name":"Genes2Me","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g","caption":"Genes2Me"},"description":"Established in 2016, Genes2Me is a leading molecular diagnostics company committed to transforming healthcare through innovative, high-quality in vitro diagnostic (IVD) solutions. Built on a strong foundation of scientific excellence and precision engineering, Genes2Me develops and manufactures advanced diagnostic technologies that enable accurate, reliable, and timely clinical decision-making across diverse healthcare settings worldwide. With a comprehensive and rapidly expanding portfolio, Genes2Me offers cutting-edge solutions across molecular diagnostics, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, RT-PCR kits and instruments, as well as nucleic acid extraction kits and automation systems. Designed to meet the evolving needs of modern laboratories and clinicians, our products combine performance, scalability, and operational efficiency. A vast majority of Genes2Me products are CE-IVD marked, reflecting our commitment to global quality benchmarks, regulatory compliance, and uncompromising product standards. At the heart of our innovation are proprietary platforms such as OnePCR and Rapi-Q, developed to deliver rapid, multiplex, and highly sensitive molecular detection with streamlined workflows and minimal turnaround time. OnePCR integrates automated nucleic acid extraction and RT-PCR into a single, seamless workflow, enabling the detection of up to 20 targets from a single sample with exceptional precision and efficiency. The Rapi-Q series is engineered for fast, sensitive, and multiplex testing with a larger throughput, empowering healthcare providers with timely diagnostic insights that support improved patient outcomes. In genomics, Genes2Me offers one of the industry\u2019s most comprehensive NGS clinical assay portfolios, spanning oncology, liquid biopsy, whole exome sequencing, NIPT and pharmacogenomics. Complementing this portfolio is EZY AutoPrep, our advanced automated library preparation workstation designed to optimize NGS library preparation through enhanced accuracy, reproducibility, and scalability. Our genomics ecosystem is further strengthened by CliSeq Interpreter, a cloud-based bioinformatics platform that enables accurate, flexible, and intuitive interpretation of complex genomic data, helping laboratories generate high-confidence insights with efficiency and ease. Driven by innovation, quality, and a global vision, Genes2Me continues to redefine the future of molecular diagnostics\u2014delivering integrated solutions that advance precision medicine and improve lives worldwide.","sameAs":["https:\/\/www.genes2me.com\/"],"url":"https:\/\/genes2me.com\/blog\/author\/admin\/"}]}},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts\/684"}],"collection":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/comments?post=684"}],"version-history":[{"count":1,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts\/684\/revisions"}],"predecessor-version":[{"id":693,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts\/684\/revisions\/693"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/media\/692"}],"wp:attachment":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/media?parent=684"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/categories?post=684"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/tags?post=684"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}